PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine and Health, University of East Anglia, Norfolk, United Kingdom.\', \'Department of Clinical Biochemistry and Immunology, Norfolk and Norwich University Hospital, Norfolk, United Kingdom.\', \'Department of Virology, Norfolk and Norwich University Hospital, Norfolk, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.00288-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34260272
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all